Prenetics Global Limited

NasdaqGM PRE

Prenetics Global Limited Dividends Paid for the year ending December 31, 2023: USD 0.00

Prenetics Global Limited Dividends Paid is USD 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

Prenetics Global Limited Dividends Paid for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
Prenetics Global Limited Dividends Paid for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
Prenetics Global Limited Dividends Paid for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
Prenetics Global Limited Dividends Paid for the year ending December 31, 2019 was USD 0.00.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

NasdaqGM: PRE

Prenetics Global Limited

CEO	Mr. Sheng Wu Yeung
IPO Date	July 16, 2021
Location	Hong Kong
Headquarters	Unit 701-706, K11 Atelier King’s Road
Employees	320
Sector	Healthcare
Industries Biotechnology Cleaning Supplies Clinical Trials Drugstores & Retail Pharmacies Eyewear Medical Instruments Personal Care Pharmaceuticals

Description

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Key trends

Past 5 years